MLL
Moody Lynn & Lieberson’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-267
| Closed | -$281K | – | 259 |
|
|
2024
Q3 | $281K | Sell |
267
-755
| -74% | -$794K | 0.02% | 217 |
|
|
2024
Q2 | $1.07M | Sell |
1,022
-3,553
| -78% | -$3.73M | 0.07% | 113 |
|
|
2024
Q1 | $4.4M | Buy |
4,575
+55
| +1% | +$52.9K | 0.3% | 60 |
|
|
2023
Q4 | $3.97M | Buy |
4,520
+4,253
| +1,593% | +$3.74M | 0.3% | 61 |
|
|
2023
Q3 | $220K | Buy |
+267
| New | +$220K | 0.02% | 197 |
|
|
2023
Q2 | – | Sell |
-4,265
| Closed | -$3.5M | – | 237 |
|
|
2023
Q1 | $3.5M | Sell |
4,265
-4
| -0.1% | -$3.29K | 0.32% | 65 |
|
|
2022
Q4 | $3.08M | Sell |
4,269
-5
| -0.1% | -$3.61K | 0.28% | 70 |
|
|
2022
Q3 | $2.94M | Sell |
4,274
-3,387
| -44% | -$2.33M | 0.28% | 66 |
|
|
2022
Q2 | $4.53M | Sell |
7,661
-384
| -5% | -$227K | 0.41% | 54 |
|
|
2022
Q1 | $5.62M | Buy |
+8,045
| New | +$5.62M | 0.41% | 51 |
|
|
2021
Q4 | – | Sell |
-6,467
| Closed | -$3.91M | – | 245 |
|
|
2021
Q3 | $3.91M | Buy |
+6,467
| New | +$3.91M | 0.29% | 73 |
|
|
2020
Q3 | – | Sell |
-9,108
| Closed | -$5.68M | – | 203 |
|
|
2020
Q2 | $5.68M | Buy |
9,108
+3,721
| +69% | +$2.32M | 0.62% | 42 |
|
|
2020
Q1 | $2.63K | Sell |
5,387
-6,557
| -55% | -$3.2K | 0.36% | 55 |
|
|
2019
Q4 | $4.49M | Buy |
+11,944
| New | +$4.49M | 0.43% | 67 |
|
|
2017
Q3 | – | Sell |
-4,170
| Closed | -$2.05M | – | 217 |
|
|
2017
Q2 | $2.05M | Sell |
4,170
-264
| -6% | -$130K | 0.27% | 71 |
|
|
2017
Q1 | $1.72M | Buy |
+4,434
| New | +$1.72M | 0.24% | 73 |
|
|
2016
Q2 | – | Sell |
-5,905
| Closed | -$2.13M | – | 163 |
|
|
2016
Q1 | $2.13M | Buy |
5,905
+2,223
| +60% | +$801K | 0.34% | 72 |
|
|
2015
Q4 | $2M | Buy |
3,682
+2,856
| +346% | +$1.55M | 0.31% | 77 |
|
|
2015
Q3 | $384K | Sell |
826
-10,130
| -92% | -$4.71M | 0.07% | 131 |
|
|
2015
Q2 | $5.59M | Buy |
+10,956
| New | +$5.59M | 0.89% | 45 |
|